Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer . 2025 studies on ivermectin for cancer Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al - A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ive...
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (41 cases) Brain Cancer (including Glioblastoma) (7 cases) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (7 cases) Cervical Cancer (2 cases) Colorectal Cancer (28 cases) Esophageal and Stomach cancer (8 cases) Endometrial Cancer (6 cases) Gastric (Stomach) cancer (refer to Esophageal and Stomach Cancer ) Head and Neck Cancer (12 cases) Kidney Cancer Case Series (12 cases) Liver Cancer (HepatoCellular Cancer) (3 cases) Lung Cancer (20 cases) Leukemia (2 cases) Lymphoma (10 cases) Melanoma (refer to Skin Cancer ) Multiple Myeloma (2 cases) Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (5 cases) Pancreatic Cancer (20 cases) Pro...
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses. Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to cancer type and stage. Ivermectin dosage should be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. Cancer dosage estimation can be adjusted based on the time that a person has to beat cancer or its risk to the patient - this includes both the cancer type and whether the ca...
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. According to oncologist Dr William Makis: “ This paper is the FI...
DMSO is a medical abbreviation for DiMethyl SulfOxide. Modern medicine often sidelines "miracle" drugs that work too well. Despite decades of evidence showing that the naturally occurring chemical Dimethyl Sulfoxide (DMSO) is a remarkably safe and versatile treatment for a range of challenging conditions — such as strokes, head trauma, spinal cord injuries, dementia, and even Down Syndrome (63) — it has been largely overlooked. This sidelining is particularly remarkable as DMSO is also one of the most effective treatments for acute and chronic pain, musculoskeletal injuries, and chronic degenerative conditions (e.g., arthritis). DMSO, Nature’s Healer DMSO is a powerful, natural compound with several unique properties that make it an incredibly versatile healing agent: Rapid absorption — When applied to the skin or ingested, DMSO quickly spreads throughout the body. ...
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin. Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias. Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...
In this Article: Introduction Ivermectin and Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (29 cases) Brain Cancer (including Glioblastoma) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories Cervical Cancer Colorectal Cancer (23 cases) Esophageal and Stomach (Gastro-Esophageal) cancer (5 cases) Endometrial (Uterine) Cancer (6 cases) Gastro-Esophageal Cancer: Fenbendazole and Ivermectin Head and Neck Cancer (5 cases) Kidney and Urinary Bladder Cancer Case Series (9 cases) Liver Cancer Lung Cancer (18 cases) Ovarian Cancer (4 cases) Pancreatic Cancer (17 cases) Prostate Cancer (21 cases) Sarcoma (2 cases) Skin Cancer (4 cases) Uterine cancer Conclusion Introduction Access to effective, cancer-specific therapies remains limited, particularly in low- and middle-income countries where cancer survival rates lag behind those in high-income settings due to i...
Parkinson’s disease, a progressive neurodegenerative disorder, affects millions worldwide, causing debilitating symptoms like tremors, rigidity, and cognitive decline. As researchers continue to explore innovative treatments, one unexpected candidate has emerged: ivermectin, a drug traditionally used to treat parasitic infections. Recent studies have sparked curiosity about its potential neuroprotective effects, prompting questions about whether this widely available medication could offer hope for managing or even slowing the progression of Parkinson’s disease. In this article, we delve into the science behind ivermectin’s potential role in Parkinson’s treatment, examining the latest research, mechanisms of action, and what this could mean for patients seeking new therapeutic options. Can Ivermectin play a key role in treating Parkinson's Disease? Two peer-reviewed papers—one by Warnecke et al. (2020) and another by Wadsworth et al. (2024)—along with a 2021 PhD thesis by Dongwook ...
Introduction The potential applications of Ivermectin and Fenbendazole in cancer treatment have sparked significant interest online, with growing communities exploring these compounds for therapeutic use. While both have roots in anti-parasitic medicine, emerging research and anecdotal evidence suggest they may offer benefits in combating prostate cancers. Can Fenbendazole and Ivermectin play a key role in treating Prostate Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might. Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients - (Case Reports in Oncology 2025) Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer (Journal of OrthoMolecular Medicine 2024) Ivermectin and Cancer: 15 Anti-cancer Mechanisms of Action Fenbendazole and Cancer: 12 Anti-Cancer Mechanisms of Action Ivermectin, Mebendazole, Metformin, High-Dose Vitamin ...
Comments
Post a Comment